Search for: "ACI Industries"
Results 81 - 100
of 231
Sort by Relevance
|
Sort by Date
4 Mar 2015, 8:35 am
Private copying levies were the subject of an industry mediation process, led by former Commissioner António Vitorino, who delivered his report on 31 January 2013 making a number of key recommendations. [read post]
27 Feb 2015, 7:21 pm
American Conference Institute (ACI) will be holding its 6th Advanced Forum on M&A and Strategic Alliances in the Life Sciences Industries from April 27-29, 2015 in New York, NY. [read post]
27 Dec 2014, 2:19 am
The Court of Justice of the European Union gave judgment in Case C-435/12 ACI Adam BV and Others v Stichting de Thuiskopie, Stichting Onderhandelingen Thuiskopie vergoeding deciding that "The amount of the levy payable for making private copies of a protected work may not take unlawful reproductions into account. [read post]
31 Oct 2014, 9:08 am
It looks to me like the problem will inevitably be left to bankruptcy courts and litigators to sort out, which drives home the extent to which the political will and leadership needed to address the problem is absent. ●One of the most interesting panels to me every year is the insurance industry panel discussing fiduciary liability and other insurance matters related to insuring risks and exposures in the benefit plan industry. [read post]
21 Oct 2014, 1:04 pm
Interestingly, I am speaking next week at ACI’s ERISA Litigation Conference in New York on conflicts of interest and other ethical issues arising with regard to ERISA litigation. [read post]
20 Jun 2014, 7:58 pm
The conference promises to present "comprehensive strategies for the generic pharmaceutical industry's present and future challenges. [read post]
6 Jun 2014, 2:25 pm
Such non-profits like Broadband for America and the American Consumer Institute (ACI), both of which claim to be “independent consumer advocacy groups” and have been fighting against classifying ISPs as a utility (a move that would make it easier to enact net neutrality rules in the future), have been shown to be heavily funded by the cable industry. [read post]
22 May 2014, 3:58 pm
Amphastar and Bioequivalence: Understanding the Implications for the Future of Biosimilars Timing is Everything: Managing the Logistics of the BPCIA Exchange Process and Preparing for "Early" and "Late" Phase Litigation Ethics in the Biosimilars Realm: Avoiding Conflicts and Maintaining Confidentiality in the Brave New World ACI is also offering a pre-conference primer on June 4 that includes two sessions: "Biosimilars 101: Comprehensive Deep Dive Into the… [read post]
7 May 2014, 9:38 pm
Much emphasis was placed on enhancing economic growth at both ends of the spectrum, highlighting benefits for the consumer (end users, libraries), the UK economy (supposedly £500 million over 10 years) and stating the existence of benefits to the right holders and creative industries (giving no example or evidence of such benefits, although maybe it is an implicit invitation to consult the impact assessments again). [read post]
13 Apr 2014, 5:30 am
http://t.co/BLFpt6yBlQ -> Link to decision of CJEU in ACI Adam BV case that copyright levies cannot apply where the source is infringing http://t.co/Jf53J75oOR -> Press release of CJEU In ACI Adam BV private copying case http://t.co/CNQ6iiKrIt -> Are Non-Practicing Entities The Problem? [read post]
11 Apr 2014, 5:30 am
" http://t.co/BLFpt6yBlQ -> Link to decision of CJEU in ACI Adam BV case that copyright levies cannot apply where the source is infringing http://t.co/Jf53J75oOR -> Press release of CJEU In ACI Adam BV private copying case http://t.co/CNQ6iiKrIt -> Are Non-Practicing Entities The Problem? [read post]
7 Apr 2014, 8:53 pm
Here is the complete agenda: On the 30th Anniversary of the Drug Price Competition and Patent Term Restoration Act: Understanding Hatch-Waxman's Transformative Impact on the Pharmaceutical Industry Assessing Pharmaceutical Patent Sustainability and Vulnerability: Strategies and Considerations for Brand Names and Generics in Anticipating, Identifying and Determining Which Patents Will be Ripe for Challenges of Invalidity and Non-Infringement Use of IPR and Other PTO Proceedings in a… [read post]
28 Feb 2014, 8:50 pm
American Conference Institute (ACI) will be holding its 8th Annual Paragraph IV Disputes conference on April 28-29, 2014 in New York, NY. [read post]
25 Feb 2014, 9:35 am
The Royal-Decree 20/2011, in force as of 1 January 2012, established that the compensation would no longer be obtained through a levy on reproduction devices but rather from the State budget (fixed at EUR 5m per each year 2012 and 2013), thus suppressing the collecting obligations for the industry. [read post]
27 Jan 2014, 10:32 am
Commissioner Barker acknowledged that the Obama Administration has used the EEOC’s enforcement litigation to “regulate” industries given the gridlock in Congress and its inability to pass worker-friendly legislation. [read post]
1 Jan 2014, 2:00 am
. **** January 6-7 Crowdfund Production Event: Aspen Investment Forum Location: Aspen, CO January 7-9 Sponsor: Opal Event: Public Funds Summit Location: Scottsdale, AZ January 8 Sponsor: Managed Funds Association Event: Treasury International Capital B Forms: Making Sense of TIC B Requirements Location: New York, NY January 9 Sponsor: 100 Women in Hedge Funds Event: A Dinner Conversation with Meg Whitman Location: Los Angeles, CA January 9 Sponsor: K&L Gates, Baker Tilly Event:… [read post]
22 Dec 2013, 8:53 pm
This is the "critical industry forum on the Leahy-Smith America Invents Act." [read post]
12 Dec 2013, 10:50 am
No other conference allows you to benchmark with the leaders in the industry who shape the future of food-borne illness policy and litigation. [read post]
29 Nov 2013, 7:16 am
This conference will not only serve as the standard for Patent Litigation Conferences going forward, but also as an annual meeting place for the "who's who" of the industry. [read post]
8 Sep 2013, 4:32 pm
ACI's FDA Boot Camp has been designed to give products or patent litigators, as well as patent prosecutors, industry in-house counsel, and life sciences investment and securities experts, a strong working knowledge of core FDA competencies. [read post]
